Breakdown | TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | -25.00K | 0.00 | 0.00 | 42.25M | 36.23M | 42.12M |
Gross Profit | -25.00K | 0.00 | -131.00K | 11.79M | 1.39M | 9.88M |
EBITDA | 323.00K | 226.00K | -2.79M | -1.15M | -9.76M | 1.35M |
Net Income | -96.00K | -801.00K | -16.83M | 665.00K | -10.11M | -7.57M |
Balance Sheet | ||||||
Total Assets | 6.23M | 6.26M | 8.56M | 56.14M | 49.95M | 73.60M |
Cash, Cash Equivalents and Short-Term Investments | 904.00K | 1.29M | 3.75M | 3.47M | 2.73M | 2.67M |
Total Debt | 0.00 | 0.00 | 0.00 | 21.18M | 20.22M | 27.79M |
Total Liabilities | 125.00K | 112.00K | 1.27M | 31.09M | 29.02M | 47.21M |
Stockholders Equity | 6.11M | 6.15M | 7.29M | 25.04M | 20.93M | 26.39M |
Cash Flow | ||||||
Free Cash Flow | -845.00K | -1.34M | -7.34M | 576.00K | -3.54M | -292.00K |
Operating Cash Flow | -845.00K | -1.34M | -7.34M | 1.40M | -2.62M | 860.00K |
Investing Cash Flow | 66.00K | -592.00K | 16.71M | -948.00K | 5.94M | -1.39M |
Financing Cash Flow | -513.00K | -513.00K | -8.84M | 297.00K | -3.16M | 1.74M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
59 Neutral | €1.67B | 48.84 | 3.35% | 2.19% | 4.28% | ― | |
51 Neutral | $578.38M | 17.54 | 7.05% | ― | 75.76% | ― | |
49 Neutral | AU$2.50B | 4.42 | -64.25% | 2.77% | 36.51% | 13.14% | |
46 Neutral | €31.59M | ― | -23.00% | ― | -2.14% | 11.40% | |
43 Neutral | AU$5.16M | ― | ― | ― | 98.35% | ||
32 Underperform | AU$5.13M | ― | ― | 7.02% | -44.64% |
Health and Plant Protein Group Limited reported a net loss after tax of $43,000 for the half-year ending 31 December 2024, a significant improvement from the $748,000 loss in the previous year. This improvement is largely due to the divestiture of its macadamia division, which halted business operations and led to the suspension of trading in HPP shares. The company is awaiting clearance of US$3.9 million from the IRS, with uncertainty over timing and amount due to processing delays. The half-year also saw a decrease in corporate overheads and an unrealized foreign exchange gain.
Health and Plant Protein Group Limited has released its half-year report for the period ending December 31, 2024. The report highlights the company’s financial performance and operational updates, providing insights into its current state and strategic direction. While specific financial figures are not detailed, the report serves as a significant update for stakeholders regarding the company’s progress and market positioning.